-
Ascentage Pharma's EED inhibitor APG-5918 has been approved for Phase I clinical trial in China and will advance the clinical development of advanced solid tumors or hematologic malignancies
Time of Update: 2023-01-05
HK) announced on November 10 that APG-5918, a class 1 embryonic ectoderm development protein (EED) inhibitor under development, has been approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) to carry out phase I clinical trials for the treatment of advanced solid tumors or hematologic malignancies.
-
New treatment for recurrent metastatic nasopharyngeal carcinoma! Professor Chen Mingyuan's team proposed a high-efficiency and low-toxicity triple GAT scheme Cell Press dialogue scientists
Time of Update: 2022-10-20
medicineMedicineRecently, the team of Professor Chen Mingyuan of the Cancer Prevention and Treatment Center of Sun Yat-sen University proposed a triple GAT program with more efficient and low toxicity potential, which provides a new treatment direction for recurrent and metastatic nasopharyngeal carcinoma.
-
【Cell】Eating late makes you hungrier and fatter! Calorie burning decreases, adipose tissue changes
Time of Update: 2022-10-13
Recommended Live/EventsOctober 21 14:00-17:30 ShanghaiBrain nervous system disease diagnosis and drug development industry salonScan the code to participate for freeNovember 01-02 09:00-17:30 ChongqingThe 1st Southwest Single Cell Omics Technology Application ForumScan the code to participate for freeNovember 25-27 09:00-17:30 ShanghaiThe 4th Shanghai International Cancer CongressScan the code to participateThis article is the original of the translational medicine network, please indicate the source when reprinting Author: JevinEating late leads to an increased risk of obesity.
-
Influence of prostatic prolapse into bladder (IPP) on postoperative positive margins and continence recovery
Time of Update: 2022-02-23
Introduction Robot-assisted laparoscopy and laparoscopic radical prostatectomy (LRP) are important methods for the treatment of localized and locally advanced prostate cancer . Intravesical Protrusi
-
Dietary fatty acids will accelerate tumor metastasis
Time of Update: 2021-12-02
In this latest study, Salvador Benitah and colleagues of the Institute of Science and Technology in Barcelona, Spain, first exposed human oral cancer and skin cancer cells to three dietary fatty acids-palmitic acid (the main saturated fatty acid in palm oil), Either oleic acid or linoleic acid-the exposure time is 4 days, and then these cells are transplanted into the corresponding tissues of mice fed a standard diet .
-
Su Shicheng: Expanding the audience for breast cancer immunotherapy
Time of Update: 2021-11-12
” Su Shicheng said, which suggests that even if PD-L1 is not expressed before treatment, combined anti-Her2 targeted therapy and anti-PD-1 /PD-L1 immunotherapy can still benefit Her2+ breast cancer patients, especially those with high macrophage infiltration .
-
KN026 combined with KN046 in the treatment of HER2-positive gastrointestinal tumors Phase Ib clinical data will be released in ESMO 2021
Time of Update: 2021-09-30
KN046-IST-02 is a phase Ib clinical study initiated by investigators in China to explore the safety and effectiveness of KN026 combined with KN046 (no chemotherapy regimen) in the treatment of HER2-positive/mutation/low expression advanced GI, as of May 2021 The preliminary research results on August 8 (mainly the effectiveness data for HER2 positive GI and the safety data of KN026 and KN046) will be announced in the form of a poster at the ESMO 2021 annual meeting on September 16.
-
PNAS discovers a new mechanism and uses imaging technology to develop new sting-activating drugs
Time of Update: 2021-09-10
A new study by scientists at the Jonsson Comprehensive Cancer Center at UCLA has found that emerging drugs that activate the protein STING (a well-established regulator of immune cell activation) substantially alter the metabolism responsible for the building blocks of DNA nucleotides.
-
Re-recognize artificial food coloring
Time of Update: 2021-02-13
chart produced by the Special Education Degree Agency is as follows, with the headline Death by Color: The Dangers of Food Coloring " , Colorful and Beautiful and Attractive Pictures Showing The Pigment Toxicity and Health Risks Associated with Our Food Coloring.
-
Sword refers to the heavy weight of the "white" medicine! Pfizer biosimilar Nyvepria (Pifegsting) approved by the U.S. FDA
Time of Update: 2020-06-16
JUNE 12, 2020 /PRNewswire/ -- Pfizer has announced that the U.S Food and Drug Administration (FDA) has approved Nyvepria (pegfilstim-apgf, Perfiertin), a biosimilar to the heavy-duty "litre white" bra
